1. Astaxanthin reduces type 2 diabetic-associated cognitive decline in rats via activation of PI3K/Akt and attenuation of oxidative stress
   XIAOBIN LI et al, 2016, Molecular Medicine Reports CrossRef
2. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome
   Tao Ding et al, 2018, Phytomedicine CrossRef
3. Role of olmesartan in ameliorating diabetic nephropathy in rats by targeting the AGE/PKC, TLR4/P38-MAPK and SIRT-1 autophagic signaling pathways
   Nesma M.E. Abo El- Nasr et al, 2022, European Journal of Pharmacology CrossRef
4. The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN DegradationIn VivoandIn Vitro
   Wei Huang et al, 2014, BioMed Research International CrossRef
5. Impact of Olmesartan Medoxomil on Amiodarone‐Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor‐ß1
   Abeer A. I. Sharaf El‐Din et al, 2016, Basic & Clinical Pharmacology & Toxicology CrossRef
6. Novel insights into NOD-like receptors in renal diseases
   Juan Jin et al, 2022, Acta Pharmacologica Sinica CrossRef
7. Olmesartan Prevented Intra-articular Inflammation Induced by Zymosan in Rats
   Gerlane Coelho Bernardo Guerra et al, 2016, Biological & Pharmaceutical Bulletin CrossRef
8. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats
   Abdul Ahad et al, 2018, European Journal of Pharmaceutical Sciences CrossRef
9. Identification of core genes and pathways between geriatric multimorbidity and renal insufficiency: potential therapeutic agents discovered using bioinformatics analysis
   Lingyun Zhang et al, 2022, BMC Medical Genomics CrossRef
10. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice
    Huan Lian et al, 2017, Biochemical and Biophysical Research Communications CrossRef
11. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats
    Mohamed A. Morsy et al, 2015, European Journal of Pharmacology CrossRef
12. Zucker Diabetic‐Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model
    Andrea N. Wang et al, 2022, Experimental Physiology CrossRef
13. Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect
    Iman O. Sherif, 2014, Journal of Physiology and Biochemistry CrossRef
14. Effect of Artemisia absinthium ethanolic extract on oxidative stress markers and the TLR4, S100A4, Bax and Bcl-2 genes expression in the kidney of STZ-induced diabetic rats
    Fatemeh Bagheri et al, 2020, Hormone Molecular Biology and Clinical Investigation CrossRef
15. Involvement of the NF-κB signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat model
    SHUJUAN QIU et al, 2016, Biomedical Reports CrossRef
16. Garlic Attenuates Plasma and Kidney ACE-1 and AngII Modulations in Early Streptozotocin-Induced Diabetic Rats: Renal Clearance and Blood Pressure Implications
    Khaled K. Al-Qattan et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
17. A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice
    Qianqian Ma et al, 2022, Frontiers in Immunology CrossRef